Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Biliary Tract Neoplasms (Phase 2)
Brain Neoplasms (Phase 1/Phase 2)
Breast Neoplasms (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 1)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Carcinosarcoma (Phase 2)
Fallopian Tube Neoplasms (Phase 1/Phase 2)
Glioblastoma (Phase 1/Phase 2)
Glioma (Phase 1/Phase 2)
Hamartoma (Phase 1/Phase 2)
Head and Neck Neoplasms (Phase 1)
Homologous Recombination (Phase 2)
Lymphoma (Phase 3)
Mutation (Phase 1/Phase 2)
Neoadjuvant Therapy (Phase 2)
Neoplasms (Phase 2)
Ovarian Neoplasms (Phase 3)
Small Cell Lung Carcinoma (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 1)
Stomach Neoplasms (Phase 3)
Triple Negative Breast Neoplasms (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue